Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle regulation and hepatocarcinogenesis.

Linda E Greenbaum1

  • 1Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA. greenbal@mail.med.upenn.edu

Cancer Biology & Therapy
|January 22, 2005
PubMed
Summary

Hepatocellular carcinoma (HCC) progresses slowly, allowing for stage identification. Early hepatocyte proliferation in preneoplastic nodules is key to HCC development and genomic alterations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis.

Alimentary pharmacology & therapeutics·2025
Same author

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.

Cell stem cell·2024
Same author

Clinical translation of liver regeneration therapies: A conceptual road map.

Biochemical pharmacology·2020
Same author

YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury.

Cell stem cell·2019
Same author

A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials.

Journal of Crohn's & colitis·2019
Same author

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.

Gastroenterology·2018

Area of Science:

  • Hepatology
  • Oncology
  • Genomics

Background:

  • Hepatocellular carcinoma (HCC) arises from chronic liver disease like hepatitis or cirrhosis.
  • The slow progression of HCC allows for the study of distinct pathological stages.
  • Early HCC development involves increased hepatocyte proliferation in preneoplastic nodules.

Purpose of the Study:

  • To understand the early events in hepatocellular carcinoma (HCC) development.
  • To identify critical regulatory pathways in HCC initiation.
  • To explore the relevance of liver cell proliferation networks to HCC pathogenesis.

Main Methods:

  • Analysis of pathological stages in HCC progression.
  • Investigating hepatocyte proliferation rates in preneoplastic nodules.
  • Characterizing regulatory networks using the partial hepatectomy model in vivo.

Main Results:

  • Increased hepatocyte proliferation is an early event in HCC progression.
  • Increased cell turnover selects for monoclonal hepatocyte populations.
  • Genomic alterations in these populations lead to HCC development.
  • Heterogeneity of genomic alterations complicates pathway identification.

Conclusions:

  • Understanding early proliferation events is crucial for HCC pathogenesis.
  • Regulatory networks governing liver cell proliferation are relevant to HCC.
  • Further research into these networks may reveal critical pathways for HCC initiation.

Related Experiment Videos